Quarterly report pursuant to Section 13 or 15(d)

INVESTMENT (Details Narrative)

v3.24.1.1.u2
INVESTMENT (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
ILiAD Biotechnologies, LLC [Member]    
Schedule of Equity Method Investments [Line Items]    
Aggregrate investment $ 7,000,000  
Book value of the investment $ 6,054,000  
Iliad [Member] | Class C Units [Member]    
Schedule of Equity Method Investments [Line Items]    
Ownership percentage not fully diluted 6.70%  
Iliad [Member]    
Schedule of Equity Method Investments [Line Items]    
Aggregrate investment $ 7,000,000  
Equity investment net loss $ 628,000 $ 674,000
Iliad [Member] | Class C Units [Member]    
Schedule of Equity Method Investments [Line Items]    
Ownership percentage fully diluted 5.40%